We focus on naturally occurring protective substances since they are more likely to be both safe and efficacious. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process. Not stressing over their therapies.
http://www.oxis.com
Founded in 1965 and headquartered in Portland, OR, OXIS International, Inc is a provider of diagnosis and treatment services for oxidative stress-related diseases. Diagnostic assays and drug monitoring assays produced by its subsidiary, OXIS Health Products, make up the bulk of its sales. Its BXT-51072 product is currently undergoing trials, and is likely to treat inflammatory bowel disease.
Oxis on Twitter
In February 2006, it moved key administrative functions to its U.S. FDA certified cGMP device manufacturing facility in Foster City, CA This blog post deals about the oxidative stress discovered by OXIS International, Inc. is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress.” Oxidative stress refers to the situations in which the body’s antioxidant and other defensive abilities to combat free radicals (a.k.a highly reactive species of oxygen and nitrogen) are overwhelmed and one’s normal healthy balance is either lost or severely compromised. Products include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates.
Oxis on facebook
Not stressing over their therapies. Founded in 1965 and headquartered in Portland, OR, OXIS International, Inc is a provider of diagnosis and treatment services for oxidative stress-related diseases. Diagnostic assays and drug monitoring assays produced by its subsidiary, OXIS Health Products, make up the bulk of its sales. Its BXT-51072 product is currently undergoing trials, and is likely to treat inflammatory bowel disease.
“When I was introduced to Mr. Lee Ben ( A Loan Officer), I was entering the market as a first time home buyer.My needs were a bit different and I had loads of questions, before he sent me my pre-approval letter, he called to speak with me about what it meant and what could change. He made himself available to me at pretty much any hour via email and texts, he was very responsive and knowledgeable. He’s also very straightforward, I explained to him what my expectations were in terms of closing time and other particulars. He said he would meet those expectations but he surpassed them. I closed so quickly my realtor and the seller of course were excited about that. But as a buyer I appreciated being walked through the process in a succinct yet thorough fashion. From pre-approval to closing- the journey was so seamless and I consider myself lucky because I’ve heard horror stories about the internet . I recommend A loan officer ben lee contact email: 247officedept@gmail.com & Whatsapp Number :+1-989-394-3740 to anyone looking for a loan in any market. Everything was handled electronically expediently and securely :)”
ReplyDelete